APEX1 and cancer: In recent years, increasing efforts have been devoted to developing novel redox inhibitors of APE/Ref-1 for cancer treatment; however, to the best of our knowledge, only a limited number of compounds exhibit promising APE/Ref-1 inhibitory effects [24,30,43,45,46].